Story

Angiolillo recognized for outstanding achievement in cardiology

Dominick Angiolillo, MD, PhD, FACC, is using his recent honor from a major international society as motivation to further his research in the field of cardiology. 

Angiolillo, an associate professor of cardiology and director of cardiovascular research at UF College of Medicine – Jacksonville, received an Outstanding Achievement Award in 2013 from the European Society of Cardiology. The accolade is for the line of research he’s conducted for over a decade on coronary artery disease and antiplatelet medications, which prevent blood clot formation.  

Angiolillo’s research has ranged from understanding the biological effects of key antiplatelet medications used in patients undergoing coronary stent procedures to contributing to the development of newer-generation antiplatelet medications. His research has been published in the New England Journal of Medicine, the Journal of the American Medical Association, Circulation, and the Journal of American College of Cardiology, among other publications.

The European Society of Cardiology presented two Outstanding Achievement Awards in 2013. According to the society, the recipients have “established themselves as independent investigators” and have had outstanding accomplishment in the “early stage of their career.”

Angiolillo picked up the award in September during the European Society of Cardiology’s annual conference in Amsterdam, the Netherlands. He’s attended the conference in years past. But this time, naturally, the experience was quite different.

“It’s an important recognition on behalf of a major cardiovascular society,” he said. “It’s nice to have been considered. The award is simply a stimulus to continue doing what I have been doing.”

Angiolillo is furthering his research by investigating a variety of blood-thinning medications in different clinical settings. Among his endeavors, he is now studying personalized antiplatelet treatment approaches, which include genetic assessments. His international recognition in the field has helped attract post-doctoral trainees from across the world to work in his research lab.

He has been a European Society of Cardiology fellow for more than 10 years. The organization is the largest cardiovascular society in the world. He serves on the Thrombosis Working Group of the society’s Council for Basic Cardiovascular Science. That group disseminates scientific knowledge about thrombosis, which is the formation of a blood clot inside a blood vessel. A fellow must belong to one of the eight working groups in order to vie for the Outstanding Achievement Award.

Angiolillo completed his medical education, residency in internal medicine and fellowship in cardiovascular disease all at The Catholic University of the Sacred Heart Medical School in Rome, Italy. He completed his fellowship in interventional cardiology at the San Carlos University Hospital in Madrid, Spain. He also earned a PhD in cellular and molecular cardiology at The Catholic University of the Sacred Heart Medical School.

Angiolillo, who joined UF in 2004, is certified by the American Board of Internal Medicine in internal medicine, cardiovascular disease and interventional cardiology. In addition to the European Society of Cardiology, he is also a fellow of several other major cardiovascular societies, including the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions.

Featured Faculty

Dominick J. Angiolillo, MD, PhD, FACC

Dominick J. Angiolillo, MD, PhD, FACC

Professor
Chief, Division of Cardiology; Medical Director, UF Health Cardiovascular Center; Medical Director, Cardiovascular Research Program; Program Director, Interventional Cardiology Fellowship; Program Director, General Cardiovascular Care Fellowship